Skip to main content Accessibility help
×
Home

Clinicopathological features of mucoepidermoid carcinoma

  • K Yamazaki (a1) (a2), H Ohta (a1) (a2), R Shodo (a1) (a2), H Matsuyama (a1) (a2) and S Takahashi (a1) (a2)...

Abstract

Objective:

We aimed to examine the clinical usefulness of a new World Health Organization classification scheme for salivary gland mucoepidermoid carcinoma, and to identify the factors most strongly associated with prognosis and outcome.

Methods:

The clinicopathological features of 45 patients who received treatment for mucoepidermoid carcinoma between 1986 and 2010 were retrospectively investigated.

Results:

The overall disease-specific 5-year survival rate was 81.8 per cent. The rate for patients with low-grade tumours (92.5 per cent) was significantly higher than that for patients with intermediate or high-grade tumours (52.2 per cent). Univariate analysis revealed that five factors were significantly associated with five-year survival: age, tumour stage classification, lymph node status, histological grade and treatment method. Four factors were significant in multivariate analysis: age, sex, tumour stage classification and lymph node status.

Conclusion:

The new World Health Organization classification was useful in predicting disease progression in patients with mucoepidermoid carcinoma. Patients with high-grade tumours or other prognostic factors positively associated with disease progression should be carefully evaluated and monitored.

Copyright

Corresponding author

Address for correspondence: Dr Keisuke Yamazaki, Department of Otorhinolaryngology, Faculty of Medicine, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-shi 951-8510, Japan Fax: +81 025 227 0786 E-mail: bymyself@med.niigata-u.ac.jp

References

Hide All
1Evans, HL. Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading. Am J Clin Pathol 1984;81:696701
2Auclair, PL, Goode, RK, Ellis, GL. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer 1992;69:2021–30
3Spiro, RH, Huvos, AG, Berk, R, Strong, EW. Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg 1978;136:461–8
4Goode, RK, El-Naggar, AK. Mucoepidermoid carcinoma. In: World Health Organization. Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. Lyon: International Agency for Research on Cancer Press, 2005;219–20
5Seifelt, G. Histological Typing of Salivary Gland Tumours, 2nd edn.Heidelberg: Springer-Verlag, 1992
6McHugh, CH, Roberts, DB, El-Naggar, AK, Hanna, EY, Gerden, AS, Kies, MS et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012;118:3928–36
7Rapidis, AD, Givalos, N, Gakiopoulou, H, Stavrianos, SD, Faratzis, G, Lagogiannis, GA et al. Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients. Oral Oncol 2007;43:130–6
8Boahene, DK, Olsen, KD, Lewis, JE, Pinheiro, AD, Pankratz, VS, Bagniewski, SM. Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience. Arch Otolaryngol Head Neck Surg 2004;130:849–56
9Lin, AC, Bhattacharyya, N. The utility of fine needle aspiration in parotid malignancy. Otolaryngol Head Neck Surg 2007;136:793–8
10Stewart, CJ, Mackenzie, K, McGarry, GW, Mowat, A. Fine needle aspiration cytology of salivary gland: a review of 341 cases. Diagn Cytopathol 2000;22:139–46
11Al-Khafaji, BM, Nestok, BR, Katz, RL. Fine-needle aspiration of 154 parotid masses with histologic correlation: ten-year experience at the University of Texas M. D. Anderson Cancer Center. Cancer 1998;84:153–9
12Vander Poorten, VL, Balm, AJ, Hilgers, FJ, Tan, IB, Loftus-Coll, BM, Keus, RB et al. The development of a prognostic score for patients with parotid carcinoma. Cancer 1999;85:2057–67
13Luukkaa, H, Klemi, P, Leivo, I, Koivunen, P, Laranne, J, Makitie, A et al. Salivary gland cancer in Finland 1991-96: an evaluation of 237 cases. Acta Otolaryngol 2005;125:207–14
14Carrillo, JF, Vazquez, R, Ramirez-Ortega, MC, Cano, A, Ochoa-Carrillo, FJ, Onate-Ocana, LF. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer 2007;109:2043–51
15Calearo, C, Pastore, A, Storchi, OF. Parotid gland carcinoma: analysis of prognostic factors. Ann Otol Rhinol Laryngol 1998;107:969–73
16Ozawa, H, Tomita, T, Sakamoto, K, Tagawa, T, Fujii, R, Kanzaki, S et al. Mucoepidermoid carcinoma of the head and neck: clinical analysis of 43 patients. Jpn J Clin Oncol 2008;38:414–18
17Mendenhall, WM, Morris, CG, Amdur, RJ, Werning, JW, Villaret, DB. Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer 2005;103:2544–50
18Hosokawa, Y, Shirato, H, Kagei, K, Hashimoto, S, Nishioka, T, Tei, K et al. Role of radiotherapy for mucoepidermoid carcinoma of salivary gland. Oral Oncol 1999;35:105–11
19Laurie, SA, Licitra, L. Systemic therapy in palliative management of advanced salivary gland cancers. J Clin Oncol 2006;24:2673–8

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed